Abstract

Designed for experts working in genome engineering, technological developments, protein design, cell building, bio-manufacturing and gene editing, the Synthetic Biology Congress will examine the latest developments in these fields in both the healthcare and plant biology sectors. New to the conference will be the addition of a third stream, focusing on Investment, Start-Ups, Strategy and Bioethics, for those looking for investment opportunities and seeking to further exploit their research. The conference will thus provide a timely interactive networking forum offering the opportunity to take home cutting edge research, strategies, methods and solutions to allow you to keep up to date with the latest advancements, novel methods and applications of Synthetic Biology within your field.